Biodegradable thermal packaging is revolutionizing the standards for transporting temperature-sensitive pharmaceuticals ...

Across the world, demand for mental-health support is exploding. Anxiety, depression, and sleep disorders are no longer ...

GSK’s Exdensur is approved by the US FDA as a twice-yearly add-on treatment for severe eosinophilic asthma in patients 12 and ...

The board of directors of Simris Group AB (publ) (“Simris Group” or the “Company”) has today resolved on a directed issue of units consisting of one (1) class B share and two (2) warrants of series ...

Expands Sobi’s pipeline with a highly differentiated new Phase 3 asset in GoutAcquisition expected to be highly accretive to Sobi’s mid- to long-term growth and margin trajectory Sobi® (STO:SOBI) has ...

Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced that its therapeutic research arm, Caris Discovery, ...

First CTA authorization marks nChroma’s transition to a clinical-stage company; first patient dosing in Phase 1/2 trial planned for early 2026 Preclinical studies demonstrated CRMA-1001 delivers ...

Lund, Sweden, 16 December 2025. Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), today announced that GOOD-IDES-02, a global pivotal Phase 3 trial in anti-glomerular basement membrane (anti-GBM) ...

Lund, Sweden, December 15, 2025. Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), today announced a reorganization of its European and International Commercial and Medical Affairs operations, ...

On 27 July 2025, the board of directors of Simris Group AB (publ) ("Simris Group" or the "Company") resolved, by virtue of the authorisation granted by the annual general meeting held on 28 May 2025, ...

PALO ALTO, CALIFORNIA / ACCESS Newswire / December 17, 2025 / Bioz, Inc., the leading AI-powered platform that transforms published scientific data into actionable product insights, is pleased to ...

AXINON® LDLp Test System receives Medical Device Authority (MDA) in Malaysianumares Health appoints BioD Medica for local distribution MDA filing for additional CE-marked product is currently in ...